Taken together, these results highlight that TIMP1 promotes macrophage M2 polarization and colorectal cancer liver metastasis via integrin-mediated signaling, and that cilengitide represents a promising therapeutic strategy to disrupt this axis. This evidence concerns the gene TIMP1 and colorectal cancer.